Skip to main content

Performance Evaluation Laboratories

Download list as CSV file
Laboratory Sort descending Country Date of Listing Laboratory Option List Analyte (s)
Biotechnology and Genetica Laboratory,Instituto Nacional de Saude (INS) Mozambique
  • Option 1
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
Biotechnology and Genetica Laboratory,Instituto Nacional de Saude (INS) Mozambique
  • Option 1
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
CDC Division of Global HIV/TB International Laboratory Branch Viral Load and Early Infant Diagnosis Team United States
  • Option 1
  • Option 2
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
CDC Division of Global HIV/TB International Laboratory Branch Viral Load and Early Infant Diagnosis Team United States
  • Option 1
  • Option 2
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
Centre For Tuberculosis, National Institute for Communicable Diseases South Africa
  • Option 1
  • Option 2
  • TB NAT
Clinical Microbiology Immunology Lab, icddr,b, Bangladesh Bangladesh
  • Option 1
  • Option 2
  • Vibrio cholerae Antigen
Clinical Reference Laboratory, Institute of Tropical Medicine (ITM) Belgium
  • Option 1
  • HIV serology
  • Syphilis serology
Clinical Reference Laboratory, Institute of Tropical Medicine (ITM) Belgium
  • Option 1
  • HIV serology
  • Syphilis serology
Clinical Reference Laboratory, Institute of Tropical Medicine (ITM) Belgium
  • Option 1
  • HIV serology
  • Syphilis serology
Clinical Reference Laboratory, Institute of Tropical Medicine (ITM) Belgium
  • Option 1
  • HIV serology
  • Syphilis serology
Clinical Reference Laboratory, Institute of Tropical Medicine (ITM) Belgium
  • Option 1
  • HIV serology
  • Syphilis serology
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
CPHL, Uganda Uganda
  • Option 1
  • Option 2
  • HPV NAT
  • HIV serology
  • HIV NAT (quantitative)
  • HIV NAT (qualitative - EID)
  • HBV NAT
  • SARS-CoV-2 NAT
  • SARS-CoV-2 Antigen RDT
Department of Bacteriology, ICMR-National Institute for Research In Tuberculosis, Chennai India
  • Option 1
  • TB NAT
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
Dept. of Immunology and serology, NITVAR, India India
  • Option 1
  • Option 2
  • HIV serology
  • HIV NAT (quantitative)
  • HBV antigen/serology
  • HPV NAT
  • HCV serology
  • HIV NAT (qualitative - EID)
  • CD4 technologies
ICMR-NIRBI, India India
  • Option 1
  • Option 2
  • Vibrio cholerae Antigen
  • HIV serology
ICMR-NIRBI, India India
  • Option 1
  • Option 2
  • Vibrio cholerae Antigen
  • HIV serology
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
NRL, Australia Australia
  • Option 1
  • Option 2
  • HBV antigen/serology
  • HBV NAT
  • HCV NAT
  • HCV serology
  • HIV serology
  • Syphilis serology
  • SARS-CoV-2 Antigen RDT
  • SARS-CoV-2 NAT
Scottish HPV Reference Laboratory United Kingdom of Great Britain and Northern Ireland
  • Option 1
  • Option 2
  • HPV NAT
Virus Reference Division, UK Health Security Agency (UK HSA) United Kingdom of Great Britain and Northern Ireland
  • Option 1
  • Option 2
  • HBV antigen/serology
Virus Reference Division, UK Health Security Agency (UK HSA) United Kingdom of Great Britain and Northern Ireland
  • Option 1
  • Option 2
  • HBV antigen/serology
Virus Reference Division, UK Health Security Agency (UK HSA) United Kingdom of Great Britain and Northern Ireland
  • Option 1
  • Option 2
  • HBV antigen/serology
Virus Reference Division, UK Health Security Agency (UK HSA) United Kingdom of Great Britain and Northern Ireland
  • Option 1
  • Option 2
  • HBV antigen/serology

.